Evidence map›Paper›PMID 32670513›Full record

ArticleMediterranean journal of hematology and infectious diseases2020

The First Case of Concomitant

Yusuke Ito, Kensuke Takaoka, Kazuhiro Toyama, Kazuki Taoka, Yoshitaka Wakabayashi, Aya Shinozaki-Ushiku, Aiko Okazaki, Kinuyo Chikamatsu, Satoshi Mitarai, Tetsuo Ushiku and 1 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. DisseminatedMicroorganisms · 2023
    Article
  2. Open forum infectious diseases · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yusuke ItoDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo.
Kensuke TakaokaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo.
Kazuhiro ToyamaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo.
Kazuki TaokaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo.
Yoshitaka WakabayashiDepartment of Infectious Diseases, The University of Tokyo Hospital.
Aya Shinozaki-UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo.
Aiko OkazakiDepartment of Infectious Diseases, The University of Tokyo Hospital.
Kinuyo ChikamatsuDepartment of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association.
Satoshi MitaraiDepartment of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo.
Mineo KurokawaDepartment of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo.
The University of Tokyo · JPJapan Anti Tuberculosis Association · JPUniversity of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is the first case of concurrent

Indexed as

Epstein-Barr virus-positive lymphoproliferative disorder (EBV-LPD)Mycobacterium genavenseProgrammed cell death 1 ligand 1 (PD-L1)

Identifiers

PMID32670513
PMCPMC7340235
OpenAlexW3042504347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.